Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

The Motley Fool Interviews Shopify Co-Founder and CEO Tobi Lutke
The Motley Fool Interviews Shopify Co-Founder and CEO Tobi Lutke
Image source: Shopify.Thirteen years ago, a computer programmer wanted to start his own business -- an online store for snowboarding equipment. In the process, he would go on to tackle a much bigger
Vertex Pharmaceuticals vs. Regeneron Pharmaceuticals: Which Company Reported Better Earnings
Vertex Pharmaceuticals vs. Regeneron Pharmaceuticals: Which Company Reported Better Earnings
Vertex Pharmaceuticals (NASDAQ: VRTX) and Regeneron Pharmaceuticals (NASDAQ: REGN) are two big-cap biotech stocks, and each recently reported second-quarter financial results that were better than
Intel Corporation Scores Another Major Design Win at Apple Inc.
Intel Corporation Scores Another Major Design Win at Apple Inc.
Intel's (NASDAQ: INTC) cellular modem business is really starting to make some inroads at Apple (NASDAQ: AAPL).After winning a deal to supply cellular modems to Apple in support of the iPhone 7-series
Better Buy: Twitter, Inc. vs. Netflix, Inc.
Better Buy: Twitter, Inc. vs. Netflix, Inc.
Netflix (NASDAQ: NFLX) built a DVD-mailing empire, then abandoned it to fulfill a much grander digital-video-streaming vision. Twitter (NYSE: TWTR) turned SMS-powered microblogging into a social
Activision Blizzard Inc. Earnings Point to More Record Growth Ahead
Activision Blizzard Inc. Earnings Point to More Record Growth Ahead
Activision Blizzard (NASDAQ: ATVI) has a habit of under promising and over delivering. The video game developer this week announced second-quarter results, and -- for the sixth consecutive time -- the
Xilinx, Inc. Beat the Street Again -- so Why Isn't the Stock Soaring?
Xilinx, Inc. Beat the Street Again -- so Why Isn't the Stock Soaring?
Reprogrammable microchip giant Xilinx (NASDAQ: XLNX) reported results last week, covering the first quarter of fiscal year 2018. The company beat Wall Street's earnings estimates for the reported
Ford Motor Co.'s Secret Weapon Pulls Through Again
Ford Motor Co.'s Secret Weapon Pulls Through Again
Ah, Ford Motor Company's (NYSE: F) secret weapon. The entity responsible for some of the most misguided bear arguments out there, and also responsible for the vast majority of company profits outside
Shopify Continues Its Torrid Growth
Shopify Continues Its Torrid Growth
Shopify Inc. (NYSE: SHOP) has been on quite a roll lately, and expectations were high going into the release of its financial results. The company, which provides software for small and medium-sized
7 Metrics Show How Apple, Inc.'s Services Business Is on Fire
7 Metrics Show How Apple, Inc.'s Services Business Is on Fire
Apple's (NASDAQ: AAPL) better-than-expected third quarter took investors by surprise earlier this week. After the report, the stock hit a new all-time high. The quarter benefited from broad-based
Why Allscripts Healthcare Solutions, Inc. Gained 12.4% Today
Why Allscripts Healthcare Solutions, Inc. Gained 12.4% Today
After announcing better-than-expected sales, an acquisition, and increased guidance for 2017, shares in Allscripts Healthcare Solutions (NASDAQ: MDRX) rallied 12.4% higher today.Allscripts
Johnson & Johnson's 3 Biggest Sources of Growth Over the Next 10 Years
Johnson & Johnson's 3 Biggest Sources of Growth Over the Next 10 Years
Healthcare conglomerate Johnson & Johnson (NYSE: JNJ) is a staple in the portfolios of conservative long-term investors and seniors alike.For decades, J&J, as the company is more commonly known, has
Delphi Raises Guidance and Remains on Road to Driverless-Car Future
Delphi Raises Guidance and Remains on Road to Driverless-Car Future
Delphi Automotive (NYSE: DLPH) wasn't on the radar of investors looking for an automotive investment until recently. That's not because anything was wrong with Delphi's business as a parts supplier
Celgene vs. Gilead Sciences: Who Reported Better Earnings?
Celgene vs. Gilead Sciences: Who Reported Better Earnings?
Celgene Corp. (NASDAQ: CELG) and Gilead Sciences (NASDAQ: GILD) reported second-quarter earnings that were better than industry-watchers' forecasts, but these two giants' circumstances are very
Why MercadoLibre Inc. Stock Fell 11% Today
Why MercadoLibre Inc. Stock Fell 11% Today
Shares of MercadoLibre (NASDAQ: MELI) fell as much as 11.7% on Friday, hitting that low around 2:45 p.m. EDT, after the Buenos Aires-based e-commerce company reported second-quarter earnings Thursday
3 Things Intel Corp. Earnings Told Us About Its Memory Business
3 Things Intel Corp. Earnings Told Us About Its Memory Business
Intel (NASDAQ: INTC) announced a decision to double-down on its non-volatile memory business about two years ago. The company said it would be converting its logic chip manufacturing facility in
Quintiles IMS Holdings Continues to Execute
Quintiles IMS Holdings Continues to Execute
Quintiles IMS Holdings (NYSE: Q), a leading service provider to the healthcare and life sciences industries, reported its second-quarter results on Aug. 3. While year-over-year comparisons continue to
3 Dividend Stocks to Buy in Your 30s
3 Dividend Stocks to Buy in Your 30s
When you're in your 30s, it's time to start getting serious about investing for the long haul. You can still afford to ride out the ups and downs of the market, but you also don't have quite as much
A Conversation With John Allison, the CEO Who Led BB&T Through the Financial Crisis
A Conversation With John Allison, the CEO Who Led BB&T Through the Financial Crisis
There are a handful of banks in the United States that have separated themselves from the competition over the past decade. One of them is BB&T (NYSE: BBT), a $221 billion bank based in Winston-Salem
Exelixis, Inc. Grows Revenue, Eyes Treating More Patients
Exelixis, Inc. Grows Revenue, Eyes Treating More Patients
Sales of Exelixis' (NASDAQ: EXEL) kidney cancer drug Cabometyx continued to grow at a torrid pace in the second quarter, allowing the company to post another profitable quarter.MetricQ2 2017Continue
Pembina Pipeline Completed Its Major Projects in Q2
Pembina Pipeline Completed Its Major Projects in Q2
You have to give credit where credit is due, and Pembina Pipeline (NYSE: PBA) has earned a lot of credit for its work over the past couple of years. This quarter featured a number of crowning
Why Teva Pharmaceutical Industries Stock Fell for a Second Straight Day
Why Teva Pharmaceutical Industries Stock Fell for a Second Straight Day
Shares of Teva Pharmaceutical Industries (NYSE: TEVA) are down 9.8% as 1:15 p.m. EDT after dropping by an even greater amount yesterday following disappointing second-quarter results and lowered
BioMarin Pharmaceutical Inc. Got It Done in the Second Quarter
BioMarin Pharmaceutical Inc. Got It Done in the Second Quarter
BioMarin Pharmaceutical (NASDAQ: BMRN) turned in a second-quarter report on Wednesday that showed it continuing to grow sales of its current drugs, getting new drugs approved, and producing promising
A Conversation With Terry Turner, CEO of Pinnacle Financial Partners
A Conversation With Terry Turner, CEO of Pinnacle Financial Partners
Nashville, Tennessee, lost its last major locally owned bank in 1999, when a larger out-of-state rival acquired First American Corp. The deal would have marked the end of an era for the city once
3 Value Stocks for Every Investor
3 Value Stocks for Every Investor
Think fast: Which type of stock offers you the best long-term appreciation prospects? If you said value stocks, give yourself a pat on the back.According to a 2016 analysis from Bank of
Why Shares of Arista Networks Are Soaring Today
Why Shares of Arista Networks Are Soaring Today
Shares of networking hardware company Arista Networks (NYSE: ANET) surged on Friday following a strong second-quarter report. Arista beat analyst estimates for revenue and earnings by wide margins